Abstract
IntroductionThe insulinotropic capacity of exogenous glucagon like peptide-1 (GLP-1) is reduced in type 2 diabetes and the insulin-resistant obese. We have tested the hypothesis that this response is the consequence...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have